Stakeholder Perspectives of the Inflation Reduction Act’s (2022) Impact on Prescription Drugs: A Narrative Review
In this review, we examine the impact of the Inflation Reduction Act (IRA) of 2022 on pharmaceutical drugs in the United States, drawing on a diverse range of sources to understand the perceptions of multiple stakeholders and professionals. Findings suggest that the Act, while aiming to control pric...
Main Authors: | Cristian Lieneck, Matthew McLauchlan, Valerie Adachi, Roger Billings |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/11/6/187 |
Similar Items
-
Is the price right? Paying for value today to get more value tomorrow
by: Sreeram V. Ramagopalan, et al.
Published: (2024-01-01) -
Profit inflation is real
by: Servaas Storm
Published: (2023-11-01) -
SECOND ROUND EFFECTS AND PASS-THROUGH OF FOOD PRICES TO INFLATION IN KENYA
by: Roseline Nyakerario Misati, et al.
Published: (2015-07-01) -
Inflation /
by: Flemming, John Stanton, 1941-
Published: (1976) -
INFLATION AND PRODUCTION COSTS OF SELECTED AGRICULTURAL PRODUCTS IN POLAND IN 2022
by: Marian Podstawka
Published: (2022-06-01)